JVM Co

JVM Co FCF/Debt

The Free Cash Flow to Debt Ratio of JVM Co (054950.KQ) as of Oct 27, 2026 is 70.28 %. In the previous year, Free Cash Flow to Debt Ratio was 85.79 % — a change of -18.08% (lower).

FCF/Debt

70.28 %

YoY

-18.08%

Last updated:

Free Cash Flow to Debt Ratio of JVM Co is 2024 70.28 % . Free Cash Flow to Debt Ratio of JVM Co was 2023 85.79 % . It decreases by -18.08% lower compared to the previous year.

The JVM Co FCF/Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF/Debt
Date
FCF/Debt
Jan 1, 2017
47.43 KRW
Jan 1, 2018
69.09 KRW
Jan 1, 2019
71.75 KRW
Jan 1, 2020
48.00 KRW
Jan 1, 2021
84.73 KRW
Jan 1, 2022
31.87 KRW
Jan 1, 2023
85.79 KRW
Jan 1, 2024
70.28 KRW
The JVM Co FCF/Debt history
YEARFCF/DebtYoY
70.28 %-18.08%
85.79 %+169.16%
31.87 %-62.38%
84.73 %+76.53%
48.00 %-33.11%
71.75 %+3.86%
69.09 %+45.67%
47.43 %+190.55%
16.32 %-9.96%
18.13 %-46.98%
34.19 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

JVM Co Stock analysis

What does JVM Co do? JVM Co., Ltd. manufactures pharmacy automation systems under the brand JVM, targeting domestic and overseas markets. The company's primary products include automatic tablet dispensing and packaging systems (ATDPSs), automatic tablet classification and packing machines available in slide, box, and drum types, total safety solutions, automatic medication vision inspection systems (VIZENs), automatic package cutting and winding systems (WIZERs), and automatic medication sorting and control systems (AccuPharm). These products are sold to customers in the pharmaceutical and healthcare sectors seeking efficient automation solutions for medication handling and safety. The firm generates revenue through the sale of its branded automation systems, with a focus on domestic distribution and international markets. JVM's product portfolio addresses key operational needs in pharmacy settings, including dispensing, classification, inspection, and sorting of medications, ensuring compliance with safety standards while improving workflow efficiency. The company's offerings are designed to meet the demands of healthcare providers and pharmaceutical manufacturers requiring advanced automation technologies. JVM's business model centers on providing comprehensive automation solutions for pharmacy operations, leveraging its established brand JVM to differentiate its products in the market. By offering a wide range of specialized systems, the company caters to both domestic and international clients seeking reliable, high-quality automation equipment for medication management and safety protocols. JVM Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about JVM Co stock

Free Cash Flow to Debt Ratio of JVM Co is 70.28 % in 2024.

Free Cash Flow to Debt Ratio of JVM Co changed from 85.79 % to 70.28 %, representing a -18.08% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow to Debt Ratio JVM Co since 2006 – with annual values, charts, and detailed analysis.

FCF/Debt measures the percentage of total debt that could be repaid from free cash flow. It is a stricter measure than OCF/Debt as it accounts for capital expenditures.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow to Debt Ratio's JVM Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — JVM Co

All Key Metrics — JVM Co